| scholarly article | Q13442814 |
| P2093 | author name string | Esquivel CO | |
| Krams SM | |||
| Martinez OM | |||
| Villanueva J | |||
| Beatty PR | |||
| Abtahi S | |||
| P2860 | cites work | Retracted: Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation | Q24679579 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1240-1247 | |
| P577 | publication date | 1998-05-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | CD30 expression identifies a functional alloreactive human T-lymphocyte subset. | |
| P478 | volume | 65 |
| Q35687821 | Advances in pre- and posttransplant immunologic testing in kidney transplantation |
| Q46095776 | Association of high post-transplant soluble CD30 serum levels with chronic allograft nephropathy. |
| Q36251308 | Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD). |
| Q79150247 | CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response |
| Q47778046 | CD4-veCD8-ve CD30+ve T cells are detectable in human lung transplant patients and their proportion of the lymphocyte population after in vitro stimulation with donor spleen cells correlates with preservation of lung physiology |
| Q28204411 | Clinical significance of serum neuron-specific enolase in patients with adult T-cell leukemia |
| Q79439040 | Evaluation of soluble CD30 as an immunologic marker in heart transplant recipients |
| Q41984840 | Expression of CD30 in patients with acute graft-versus-host disease |
| Q80309091 | Immunological monitoring after organ transplantation: potential role of soluble CD30 blood level measurement |
| Q34482699 | Increased bone marrow (BM) plasma level of soluble CD30 and correlations with BM plasma level of interferon (IFN)-γ, CD4/CD8 T-cell ratio and disease severity in aplastic anemia |
| Q44966896 | Increased plasmacytoid dendritic cells and RORγt-expressing immune effectors in cutaneous acute graft-versus-host disease |
| Q40713321 | Optimisation of the CT h4S bioassay for detection of human interleukin-4 secreted by mononuclear cells stimulated by phytohaemaglutinin or by human leukocyte antigen mismatched mixed lymphocyte culture |
| Q34293431 | Phenotypic characterization of subsets of T cell lymphoma: towards a functional classification of T cell lymphoma |
| Q85224322 | Post-transplant monitoring of soluble CD30 level as predictor of graft outcome: a single center experience from China |
| Q98466664 | Pre-existing Alloreactive T and B Cells and Their Possible Relevance for Pre-transplant Risk Estimation in Kidney Transplant Recipients |
| Q51969986 | Pre-transplant level of soluble CD30 is associated with infection after heart transplantation. |
| Q45209562 | Preceeding the rejection: in search for a comprehensive post-transplant immune monitoring platform |
| Q44215754 | Predicting renal graft failure by sCD30 levels and de novo HLA antibodies at 1year post-transplantation |
| Q73076834 | Regulation of antigen-induced human T-lymphocyte responses by calcineurin antagonists |
| Q86104164 | Soluble CD30 does not predict late acute rejection or safe tapering of immunosuppression in renal transplantation |
| Q88375262 | Soluble CD30, Acute Rejection, and Graft Survival: Pre- and 6-Month Post-Transplant Determinations-When Is the Best Time to Measure? |
| Q43274504 | TH1/TH2 cytokines and soluble CD30 levels in kidney allograft patients with donor bone marrow cell infusion. |
| Q34719084 | The role of TNF receptor and TNF superfamily molecules in organ transplantation |
Search more.